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Abstract
In August 2013, the National Institutes of Health sponsored a conference to address major gaps in 
our understanding of the epidemiology, pathophysiology, and management of fecal incontinence 
(FI) and to identify topics for future clinical research. This article is the first of a two-part 
summary of those proceedings. FI is a common symptom, with a prevalence that ranges from 7 to 
15% in community-dwelling men and women, but is often underreported as providers seldom 
screen for FI and patients do not volunteer the symptom, even though the symptoms can have a 
devastating impact on quality of life. Rough estimates suggest that FI is associated with a 
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substantial economic burden, particularly in patients who require surgical therapy. Bowel 
disturbances, particularly diarrhea, the symptom of rectal urgency, and burden of chronic illness 
are the strongest independent risk factors for FI in the community. Smoking, obesity, and 
inappropriate cholecystectomy are emerging, potentially modifiable risk factors. Other risk factors 
for FI include advanced age, female gender, disease burden (co-morbidity count, diabetes), anal 
sphincter trauma (obstetrical injury, prior surgery), and decreased physical activity. Neurological 
disorders, inflammatory bowel disease, pelvic floor anatomical disturbances (rectal prolapse) are 
also associated with FI. The pathophysiological mechanisms responsible for FI include diarrhea, 
anal and pelvic floor weakness, reduced rectal compliance, and reduced or increased rectal 
sensation; many patients have multi-faceted anorectal dysfunctions. The type (urge, passive or 
combined); etiology (anorectal disturbance, bowel symptoms or both); and severity of FI provide 
the basis for classifying FI; these domains can be integrated to comprehensively characterize the 
symptom. Several validated scales for classifying symptom severity and its impact on quality of 
life are available. Symptom severity scales should incorporate the frequency, volume, consistency, 
and nature (urge or passive) of stool leakage. Despite the basic understanding of FI, there are still 
major knowledge gaps in disease epidemiology and pathogenesis, necessitating future clinical 
research in FI.
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Introduction
Fecal incontinence (FI) is defined by the unintentional loss of solid or liquid stool and anal 
Incontinence (AI) includes leakage of gas and/or FI. The emotional consequences of AI 
often exceed the physical manifestations. Many individuals report withdrawing from their 
social lives and hide the problem from their families, friends, and even their doctors. This 
has led to difficulties for healthcare providers in identifying those affected by FI. Since FI is 
strongly associated with age its incidence will likely increase as the population ages. Disease 
prevention has been hindered by limited research and incomplete knowledge about the 
biological causes and interacting social and environmental factors.
To address these issues, the National Institute of Diabetes and Digestive and Kidney 
Diseases (NIDDK) organized a workshop in August 2013, where a panel of experts in 
epidemiology, gastrointestinal physiology, gastroenterology, colorectal surgery, 
urogynecology, and psychology were invited to identify and discuss major issues in the 
diagnoses and treatment of FI/AI. We examined the barriers encountered in addressing 
FI/AI, and identified research priorities in both basic and clinical research to further advance 
treatment of the condition. This two-part document will summarize the principal findings of 
the workshop.
Prevalence
Many studies that evaluated the prevalence of FI were conducted in selected populations. 
For example, only 8 of 34 surveys in a review from 2004 were community-based and 
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sampled the entire population i.e. were unrestricted by age, residence, or underlying disease 
(1). However, 4 of these 8 studies surveyed fewer than 750 subjects, and only two studies, 
which were conducted in a market mailing sample and in Wisconsin households (2, 3), were 
from the United States. Table 1, which summarizes the large population-based studies on the 
epidemiology of FI, includes studies that were summarized in that review (2–7) and 6 others 
published thereafter (8–13). These studies suggest that FI is common with a prevalence 
ranging from 7 to 15% in community-dwelling women. The prevalence is comparable in 
men (6, 13).
Besides true differences, the variations in prevalence across studies may reflect differences 
in survey methods (e.g., by phone or in person), the screening questions, the reference 
timeframe, and the definition of incontinence. In particular, the prevalence of anal 
incontinence, which includes incontinence for flatus as well as feces, is higher than FI. An 
internet-based survey suggests that women prefer the term 'accidental bowel leakage' (ABL) 
over fecal or bowel incontinence (14). Indeed, some surveys were anchored by the validated 
question “How often have you experienced accidental leakage of solid or liquid stool over 
the past year” (8, 15)? Other surveys assessed prevalence over the preceding month (13).
The prevalence of FI is higher among care-seeking populations, home-care populations, and 
adults in long-term care settings (1). In some (9, 11, 16, 17) but not all (13, 18) studies, the 
prevalence is lower in African American relative to white women, but is equal in African 
American and white men (13, 18).
The incidence rate of FI in a population has only been evaluated in two studies (16, 19). In a 
study of community-dwelling adults aged 65 and older, the incidence rate of FI over 4 years 
was 17% (13.7, 20.1), with 6% (4.0, 8.3) developing FI at least monthly (16). Controlling 
for age, comorbidity count, and BMI, significant independent risk factors for incident FI in 
women were white race, depression, chronic diarrhea, and urinary incontinence (UI). UI was 
the only significant risk factor for incident FI in men. In a study of community-dwelling 
women aged 50 years and older the incidence rate of FI was 7.0% (5.0–9.6) ten years after 
the initial survey. At baseline, self-reported diarrhea (odds ratio [OR]=3.8 [1.5, 9.4]), 
incomplete evacuation (OR=3.4 [1.2, 9.8]), and pelvic radiation (OR=5.1 [1.01, 25.9]) 
predicted development of FI. Development of urgency was the primary predictor among the 
set of predictors reflecting changes in bowel symptoms that were associated with the onset 
of FI (OR=24.9 [10.6, 58.4]). However, the natural history of FI is unknown.
Finally, some, but not all studies suggest that FI is associated with increased mortality (20–
22). However in the studies which link FI with increased mortality, it is unclear whether 
increased mortality is related to FI per se or conditions associated with FI since the number 
of chronic illnesses is known to be a risk factor for FI (13).
Patient Suffering and Caregiver Burden
FI can have a devastating impact on daily life. The inability to control an important bodily 
process results in a loss of confidence, self-respect, modesty, and composure (23). These 
consequences are compounded by the social stigma attached to FI and the secrecy attached 
to the condition. Hence, many people with FI do not share the condition with their closest 
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friends and relatives, let alone care providers. Indeed, sometimes they tend to withdraw from 
family, friends, and even their spouses. Providers who did not screen for FI considered it 
less important to screen for FI compared with other health issues such as increased 
triglyceride levels, diabetes, excessive use of alcohol, and urinary incontinence (24).
Caregiver burden is also significantly greater for FI than for urinary incontinence as 
measured by hours of care (25), emotional distress and health deterioration in family 
caregivers (26), and willingness to consider admitting the incontinent relative to a nursing 
home (26, 27).
Healthcare Seeking Behavior in FI
Recognizing FI is a prerequisite to managing the symptom and providing support to patients. 
However, FI is under recognized; for example, in one study less than one third of patients 
with FI had disclosed this to a provider (28). This occurs because providers seldom screen 
for FI and patients do not volunteer the symptom. Among women presenting for benign 
gynecologic care, only 17% with FI were asked about the symptom by their health care 
provider (29). Only 2.7 percent of patients with selfreported FI also had a medical diagnosis 
(30). The extent to which this problem is explained by limited awareness of the prevalence, 
burden, and management of FI, by insufficient time during visits or by other factors is 
unknown (31). There is a lack of consensus on how to screen for FI.
Factors that are associated with care seeking for FI include more frequent and severe FI 
symptoms (8, 30, 32), symptoms that are perceived as dangerous (e.g., pain) (33), loss of 
solid stool, having an established primary care provider, and having knowledge of FI (32). 
Conversely, less frequent and less severe FI (8), and lower embarrassment as measured by 
the FIQOL questionnaire (29) are associated with lower rates of consulting. Barriers to 
seeking care include a lack of understanding of the term fecal incontinence, embarrassment, 
the belief that FI is a normal part of aging, unfamiliarity with whom to discuss this problem, 
priority of other medical conditions, concerns that there are no options to treat FI, and 
pessimism that physicians will be able to help (8, 29, 31). For example, an internet-based 
survey observed that only 30% of nearly 1100 community dwelling women with FI had 
heard the term “fecal incontinence”; a majority (71%) preferred the term “accidental bowel 
leakage” to describe their condition (14). A more patient centered term (e.g., accidental 
bowel leakage) may expand opportunities for sufferers to seek care, as was seen when the 
term “impotence” was replaced by “erectile dysfunction” or ED.
Economic Impact
The burden and economic impact of FI includes direct (personal hygiene products, 
ambulatory care visits, diagnostic testing, medical and surgical management) and indirect 
(loss of productivity and necessary alterations in living environments such as nursing home 
placement) costs. Because the disease is chronic, it is challenging to measure the economic 
impact particularly as the efficacy of treatments declines over time; data on both direct and 
indirect costs are extremely limited. In addition, FI rarely occurs as an isolated condition and 
therefore, attributing costs to the appropriate disease state can be very difficult. FI increases 
the likelihood that an older patient will be admitted to a nursing home rather than cared for 
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at home (34–36). This factor, in addition to the indirect costs of lost productivity, likely 
represents the largest economic burden of FI.
Two studies have attempted to evaluate the full cost burden of FI. The total per patient 
annual cost of FI, adjusted to 2012 dollars, was higher in the US (i.e., $4,111) than the 
Netherlands (i.e., $3,521) (37, 38). Data from a health management organization suggest 
that in 2005, health care visits and the annual actual cost was $2,897 higher in people with 
than without FI (30). However it is unclear if this difference is related to FI per se or 
comorbid medical conditions.
The current surgical costs of FI are similarly difficult to estimate. Based on a review of 
approximately 3,500 surgeries performed over a 5-year interval for FI, the total hospital 
costs were $34.1 million (adjusted to $2012) which is relatively low compared to the 
surgical management of urinary incontinence. This surgical cost estimate, however, was 
derived before the Food and Drug Administration approved newer surgical modalities for FI 
management including sacral nerve stimulation (SNS) and perianal bulking agents.
The potential economic impact of these new surgical treatment modalities is sizable. For 
example, in Europe, the estimated 5-year cumulative cost for SNS is seven times higher than 
conservative treatment (39). Expressed differently, in the United Kingdom, they calculated 
that each increment in quality-adjusted life year gained with SNS for FI cost over $35,000. 
No such calculation has yet been reported in the US but would likely be even higher as the 
cost of performing the procedure, even for Medicare patients (i.e., approximately $16,500 
for the device and $6800 for surgical fees) is greater in the US than in Europe. For those 
with commercial insurance, the costs are even higher. In summary, while diagnostic 
investigations for FI are relatively inexpensive, our understanding of the direct cost of FI is 
incomplete particularly since the introduction of the high-cost treatment modality of SNS. 
There are no prospective studies comparing the cost effectiveness of SNS and conservative 
therapy. Relatively little is known about the indirect costs of FI. Cost effectiveness should 
be considered when developing and evaluating diagnostic and treatment algorithms. As the 
population ages, the prevalence of FI and the associated financial burden will likely increase 
(9).
Symptom Severity and Impact on Quality of Life
There are over 20 scales for rating the severity of FI. Those developed prior to 1992 are 
reviewed elsewhere (40) and are rarely used. Thereafter, 6 other scales – the Pescatori, 
Wexner (Cleveland Clinic), Vaizey (St Marks), Rockwood, Modified Manchester Health 
Questionnaires, and the Fecal Incontinence and Constipation Assessment (FICA) FI 
symptom severity instrument – have been developed and used in clinical studies to rate the 
severity of FI (8, 15, 40–51). The Bowel version of the International Consultation of 
Incontinence questionnaire (ICIQ-B) and the Revised Fecal Incontinence scale are the most 
recently developed and validated instruments; however, they have not been widely used in 
clinical studies (52–54). These 8 scales which have been at least partly validated are 
summarized in Table 2.
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All scales for rating the severity of FI incorporate the type and frequency of leakage. Some 
scales (i.e., Vaizey, FICA, and ICIQ-B) also incorporate rectal urgency (8, 43, 44, 52), 
which is often unpredictable, and causes much distress to people with FI (23). Patients with 
urge FI and rectal hypersensitivity have more frequent stools, use more pads, and report 
more lifestyle restrictions compared to patients with normal rectal sensation (55). Only one 
scale (i.e., the FICA FI symptom severity scale) incorporates the amount of leakage, which 
we deem essential for characterizing the severity of FI (52) (Table 2). Indeed, absent an 
assessment of the amount of leakage, the severity of FI would be rated as identical for two 
subjects, one of whom had minor staining and the other a large liquid incontinent bowel 
movement once a week.
FI can have a devastating impact on quality of life (QOL), which can be evaluated by 
generic or disease-specific instruments. Some symptom severity scales also include typically 
one (41, 43, 53), sometimes more (52) questions related to impact of FI on QOL. The 
alternative approach is to use dedicated instruments with more questions that provide a more 
refined assessment of the impact of FI on QOL (e.g., Rockwood Fecal Incontinence Quality 
of Life Scale, modified Manchester Health Questionnaire, and FICA QOL scale) (44, 45, 
56). There is a significant correlation between symptom severity and QOL in FI (42, 44). 
The Pelvic Organ Prolapse/Incontinence Sexual Questionnaire—IUGA Revised is validated 
in women with FI, allowing for measurement of sexual function with a condition-specific 
measure (57).
A recent study highlighted patients perspectives of the severity of FI and its impact on 
quality of life. Patients reported that poor bowel control restricted social life; other issues 
pertained to toilet location, hygiene/odor issues, coping strategies, fear, physical activities, 
embarrassment and unpredictability of bowel habits (52). Certain QOL instruments (e.g., 
Rockwood Fecal Incontinence Quality of Life Scale), comprehensively address issues 
identified by patients.
Bowel diaries are a commonly used research tool for objective measurement of condition 
severity but can be limited by poor patient adherence. These limitations to paper diaries can 
be mitigated by internet and telephone-based daily reporting of symptoms, although older 
people who are at greatest risk of FI may not be comfortable with these technologies. Given 
the limitations in objective, global, and diary measures, FI assessment is likely to remain 
reliant on symptom severity and QOL scales.
Etiology, Associated Conditions, and Risk Factors
Knowing which clinical conditions and patient characteristics are strongly associated with FI 
is important because these identify patients who are at risk for FI and who should be 
targeted for screening and prevention strategies (Table 3). In general, the term “etiology” is 
used in clinical practice while epidemiological studies identify associated conditions and 
risk factors. Only epidemiological studies that assess the temporal relationship between FI 
and associated conditions can identify risk factors, which precede the onset of FI.
Few epidemiological studies have comprehensively evaluated the risk factors for FI in the 
community. In community surveys, bowel disturbances, particularly diarrhea, the symptom 
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of rectal urgency, and burden of chronic illness rather than obstetric history (e.g., forceps 
use, complicated episiotomy) are by far the most important independent risk factors for fecal 
incontinence (13, 19, 58–61). Specifically, in a community-based cohort of 176 randomly 
selected women with and 176 without FI, independent risk factors for FI were diarrhea (53 
[6.1–471], mean odds ratio [95% CI]), cholecystectomy (4.2 [1.2–15]), current smokers (4.7 
[1.4–15]), rectocele (4.9 [1.3–19]), stress urinary incontinence (3.1 [1.4–6.5]), and BMI (per 
unit, 1.1 [1.004–1.1]). A history of smoking and obesity are emerging and potentially 
modifiable risk factors (9, 11, 17, 60, 61); smoking is also a risk factor for external sphincter 
atrophy by MRI (61). The mechanisms by which obesity predisposes to FI are incompletely 
understood (62). Other conditions associated with FI include advanced age, disease burden 
(co-morbidity count, diabetes), anal sphincter trauma (obstetrical injury, prior surgery), and 
decreased physical activity (3, 9, 13, 17, 63).
Several diseases that can cause anorectal sensorimotor dysfunctions and/or altered bowel 
habits are associated with FI in clinical practice (Table 3). Some of these conditions do not 
emerge as risk factors in community studies possibly because their prevalence is relatively 
low. Consistent with the findings of community-based studies, the vast majority of women 
with FI who consult a physician do not have a neurological or inflammatory disorder but 
rather bowel disturbances, typically diarrhea, perhaps associated with a history of obstetric 
risk factors.
Obstetric trauma
The relationship between obstetric anal sphincter injury and FI may be summarized as 
follows. The incidence of FI following vaginal delivery appears to be declining from rates of 
13% of primiparous women two decades ago (64) to 8% in the most recent series (65). This 
may reflect improvements in obstetrical practices including decreased use of instrumented 
vaginal delivery (forceps and vacuum extraction), and more selective use of episiotomy. 
Obstetric anal sphincter injury is a significant risk factor for postpartum FI (66). However, 
and similar to urinary incontinence, the available studies indicate that obstetric anal 
sphincter injury is not, after adjusting for bowel disturbances (60), a major risk factor for FI 
occurring many decades after vaginal delivery in women. Among women in the community 
the median age of onset of FI is the 7th decade, i.e., many decades after vaginal delivery (60, 
61). Moreover, the prevalence of FI is similar in men and women. Post partum AI results 
from vaginal delivery rather than pregnancy or labor. Epidemiologic studies show similar 
rates of AI and FI between nulligravid and nulliparous women, and prospective 
observational studies demonstrate that rates of AI do not significantly change throughout 
pregnancy (67–70). Similarly, comparisons of rates of AI in labored and unlabored cesarean 
sections show no significant differences in either epidemiologic surveys or prospective 
observational trials (68, 71, 72). Third degree (i.e., involving the external anal sphincter) and 
fourth degree lacerations (i.e., extending through the external and internal anal sphincters) 
are strong risk factors for anal and fecal incontinence. A prospective trial conducted by the 
NIH/NICHD Pelvic Floor Disorders Network matched women with sphincter injury to a 
vaginal delivery without recognized sphincter injury control group and identified a nearly 
twofold increase in the odds of FI (73). Among deliveries requiring instrumentation, the risk 
is highest for instrumented (forceps and vacuum) deliveries with increased odds of 1.5 for 
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AI and higher risk with forceps than vacuum (74). Cesarean delivery obviously minimizes 
the risk of anatomic anal sphincter injury, but does not universally protect against 
development of FI/AI. The 2006 NIH consensus conference on cesarean delivery on 
maternal request concluded that there was insufficient evidence to support a practice of 
elective Cesarean delivery for the prevention of pelvic floor disorders, including FI. Thus, 
there are likely inherent predispositions (i.e., genetic) in some women, that when exposed to 
an event such as childbirth or other factors (i.e., obesity and age) results in expression of the 
disorder. Our understanding of the relationship between obstetric injury and FI/AI is based 
on cross-sectional and case-control studies because randomized trials are not feasible.
FI in the Elderly
The prevalence of FI is 15% in community dwelling older people (13), 18–33% in hospitals, 
38% in home health, and 50–70% in nursing homes (75–77). Among community dwelling 
elderly, the incidence of FI (i.e., new onset FI), ranges from 7% over 10 years to 17% over 4 
years (16, 19). Within 10 months of admission to nursing homes, 20% of those continent at 
admission develop FI (20), suggesting that nursing home practices may contribute to FI but 
may also be related to the high comorbidity burden and low functional status of persons 
admitted to nursing homes. Older adults frequently do not report FI. Providers screen for FI 
among patients in nursing homes but not in the community (78).
Dementia (20, 28, 79), mobility impairment (80, 81), and comorbid chronic diseases (18, 20) 
are more significant risk factors for FI in older adults. Constipation with fecal impaction is a 
significant risk in nursing homes (20, 81). Cross-sectional studies suggest that age is 
associated with alterations in anorectal functions (i.e., lower anal resting and squeeze 
pressures, anal sphincter denervation, increased rectal compliance, and decreased rectal 
sensation) (82–85). These changes may predispose to FI.
Several studies have evaluated the effects of various interventions in nursing home residents. 
Prompted toileting and regular fitness training reduced the frequency of FI from 8% to 0% 
of incontinence checks and increased the proportion of continent bowel movements from 
0% to 75% (86). In a separate study, a program of prompted toileting, fitness training, and 
increased fluid intake was accompanied by more bowel movements and continent stools but 
there was no change in the number of incontinent bowel movements (87). However, 89% of 
these patients had an underlying evacuation disorder. In a trial comparing lactulose alone to 
lactulose plus glycerin suppositories, residents who had complete rectal emptying as 
determined by a rectal examination, also had fewer FI episodes and soiled less frequently 
(88). Finally, a perineal washcloth with dimethicone reduced incontinence-associated 
dermatitis from 22% to 8%; while water and pH neutral soap had no effect (89).
Mechanisms of Normal Fecal Continence and Pathophysiology of Fecal 
Incontinence
Fecal continence is maintained by anatomical factors, recto-anal sensation, and rectal 
compliance (90) (Figure 1). The internal anal sphincter, which is made of circular smooth 
muscle, maintains approximately 70% of anal resting tone. The external anal sphincter, 
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comprised of striated muscle, accounts for the remaining component of resting tone. The 
puborectalis is a U-shaped component of the levator ani complex that also helps maintain 
the rectoanal angle at rest. The external sphincter, puborectalis, and levator ani can be 
voluntarily contracted further to preserve continence. Rectal distension by stool induces 
rectal contraction, the sensation of urgency, and reflex relaxation of the internal anal 
sphincter. Thereafter, if socially convenient, the pelvic floor muscles relax followed by 
defecation. If not, rectal contractions and the sensation of urgency generally subside as the 
rectum accommodates to continued distention. This, together with voluntary contraction of 
the external anal sphincter and puborectalis muscles, permits defecation to be postponed 
when necessary.
Bowel disturbances, typically diarrhea, and/or anorectal dysfunctions (i.e., anal sphincter 
weakness, reduced rectal compliance, increased or reduced rectal sensation) can cause FI 
(91, 92). Many patients have more than one disturbance (93). A majority of older women 
with FI have reduced anal resting and/or squeeze pressures, reflecting weakness of the 
internal and/or external anal sphincters respectively (94). Anal sphincter damage, which is 
most frequently caused by obstetric or iatrogenic trauma, or neurogenic injury can cause 
anal weakness. The association between sphincter injury documented by imaging and 
weakness is incompletely understood. Neurogenic lesions can occur at any level of the axis 
extending from the central nervous system to the external anal sphincter (85). The most 
common causes of neurogenic injury include a peripheral neuropathy (e.g., due to diabetes 
mellitus), pudendal nerve stretch injury, or obstetric injury. Moreover, recent studies suggest 
that even asymptomatic older nulliparous women have anal sphincter neurogenic injury, 
which partly explained weak squeeze pressures (85). Since needle EMG is the only available 
technique for documenting neurogenic injury, newer, and preferably less invasive 
approaches are necessary (95).
In addition to anal sphincter injury, FI is also associated with atrophy, denervation, and 
impaired function of the puborectalis muscle (94). Excessive straining may cause increased 
perineal descent, which can stretch and thereby damage the pudendal nerve and also make 
the anorectal angle more obtuse.
Patients with FI may have normal, reduced, or increased rectal sensation (94, 96). When 
rectal sensation is reduced, the external anal sphincter may not contract promptly when the 
rectum is distended by stool, predisposing to FI. Conversely, rectal hypersensitivity in FI 
may be partly secondary to an exaggerated contractile response to distention, and/or reduced 
rectal capacity, and may explain the symptom of rectal urgency (93, 94, 97–99). The 
pathogenesis of a smaller rectal reservoir, which may predispose to FI particularly when 
associated with anal weakness, is unknown. Finally, some patients with fecal seepage have 
high anal pressures and impaired rectal evacuation (100). Such patients may benefit from 
biofeedback retraining not only to improve rectal sensation and rectal coordination, but also 
to improve abdomino-pelvic coordination during defecation.
In summary, multiple physiological mechanisms preserve continence. Deficits in any of 
these mechanisms may contribute to FI, and as a consequence no single physiological 
measure is consistently associated with FI. Treatments that target only one mechanism (such 
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as sphincter weakness) are unlikely to benefit all patients with FI. It is unknown if the 
phenotype based on symptoms and pathophysiological mechanisms is useful for guiding 
therapy for FI.
Classification of Fecal Incontinence
An ideal system for classifying FI would preferably be user friendly and preferably require 
less testing, provide discrete categories with minimal overlap among categories, be related 
to underlying mechanisms, and guide therapy and also predict the response to therapy. In 
contrast to urinary incontinence, there is no widely-accepted approach for classifying FI. 
Currently, FI is classified by separate systems based on etiology (Table 3), pathophysiology 
(i.e., bowel disturbances, anorectal dysfunctions), type of leakage (urge, passive, or 
combined), or symptom severity scales. At this meeting, it was proposed that these domains 
can be incorporated into a new system to comprehensively characterize FI. Consideration 
should be given to further developing this classification.
Suggestions for Future Research
Table 4 summarizes the topics for future research in the epidemiology and pathophysiology 
of fecal incontinence. These topics are an extension of the gaps in our current knowledge 
identified in this document.
Summary
FI is a common, but often under-recognized symptom, which can affect both men and 
women. Patient centered terms such as accidental bowel leakage may be preferable to 
medical terms (e.g., fecal incontinence) in communication with the public. Particularly when 
severe, the symptom can substantially impair quality of life and based on limited data, have 
a substantial economic impact. Symptom severity and quality of life can be quantified by 
questionnaires. Community studies suggest that bowel disturbances, particularly diarrhea, 
are the strongest risk factors for FI. Deficits in any of the multiple physiological mechanisms 
that preserve continence may also contribute to FI. There is considerable scope for 
enhancing our understanding of these issues, thereby facilitating identification of FI and 
improving the lives of people who have the symptom.
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What is current knowledge?
• FI is a common symptom and can have a devastating impact on quality of life 
but is often underreported.
• The strongest independent risk factors for FI in the community are bowel 
disturbances, especially diarrhea, the symptom of rectal urgency, and burden of 
chronic illness.
• Diarrhea, anal and pelvic floor weakness, reduced rectal compliance, and 
reduced or increased rectal sensation contribute to FI; many patients have multi-
faceted anorectal dysfunctions.
• Symptom severity in FI and its impact on quality of life can be classified by 
validated scales. Symptom severity scales should incorporate the frequency, 
volume, consistency, and nature (urge or passive) of stool leakage.
What is new here?
• Despite the basic understanding of FI, there are still major knowledge gaps in 
epidemiology and pathogenesis, necessitating future clinical trials.
• Several topics for future research were identified in this conference and 
summarized in this article.
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Figure 1. Mechanisms of Normal and Disordered Fecal Continence
In addition to formed stools, anatomical factors, recto-anal sensation, and rectal compliance 
contribute to fecal continence. Conditions which affect stool consistency, impair rectal 
capacity or sensation, weaken the anal sphincters and pelvic floor weakness, limit mobility 
or mental faculties result in FI.
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Table 1
Epidemiology of Fecal Incontinence: Community-Based Studies




Talley (1992) (4) Olmsted County residents ≥65 years; Mailed 
questionnaire
66% (328) FI once per week over past year – 3.1% 
(F); 4.5% (M)
Drossman (1993) (2) US householder marketing list; Mailed 
questionnaire
66% (5,430) Soiling – 6.9 % (F); 7.4 % (M)
Gross incontinence – 0.9% (F); 0.5% 
(M)
Nelson (1993) (3) Wisconsin residents of all ages; Phone interview 
with 1 member in each household
73% (6,959) Any FI over past year – 2.2% (overall)
7.5% (aged ≥ 65)
Reilly (1994) (5) Olmsted County residents ≥50 years; Mailed 
questionnaire
64% (1,540) Any FI – 17.8% (F); 12.8% (M)
Walter (2002)(7) County of Ostergotland (Sweden); aged 31–76 
years; Mailed questionnaire
81% (1610) Liquid FI > 1/month – 10.9% (F); 9.7% 
(M)
Solid FI > 1/month – 1.4% (F); 0.4% 
(M)
Perry (2002)(6) Leicestershire Health Authority (UK) patient 
register; Mailed questionnaire
70% (10,226) Any FI – 5.7% (F); 6.2% (M)
Bharucha (2005)(8) Olmsted County residents ≥20 years; Mailed 
questionnaire
53% (2800) Any FI – 14% (F)
Melville (2005)(9) HMO population, 30–90 years, Washington State; 
Mailed questionnaire
64% (3536) Loss of liquid or stolid stool once/
month – 7.7% (F)
Quander (2006)(10) Chicago Health and Aging Project, ≥65 years, door-
to-door survey of 1 household member
79% (6158) Any FI (“past few months”) – 9.6%. No 
differences between men and women
Varma (2006)(11) Reproductive Risks for Incontinence Study at 
Kaiser, ≥40 years with ≥50% of deliveries at 
Kaiser, mailed questionnaire
2109 Any fecal incontinence in past 12 
months – 25% (F)
Nygaard (2008) (12) 
and Whitehead (2009) 
(13)
National Health and Nutrition Examination Survey 
(2005–2006), men and women ≥20 years, door-to-
door interview
64% (4308) Loss of liquid or stolid or mucus stool 
during the last 30 days – 8.9% (F); 7.7% 
(M)
Prevalence rates for males (M) and females (F) are provided separately where available
FI = fecal incontinence.
Reproduced with permission from Bharucha AE. Epidemiology of Fecal Incontinence. In: Talley NJ, Locke GR III, Moayyedi P, West J, Ford AC, 
Saito YA, eds. GI Epidemiology: Diseases and Clinical Methodology, 2nd ed. Chichester (UK): Wiley Blackwell, 2013, p. 285–295.
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Table 3
Pathogenesis and Etiology of Fecal Incontinence
Anal sphincter weakness
  Injury - obstetric trauma, related to surgical procedures, e.g. hemorrhoidectomy internal sphincterotomy, fistulotomy,
  Non-traumatic – scleroderma, internal sphincter thinning of unknown etiology
  Neuropathy - stretch injury, obstetric trauma, diabetes mellitus
Anatomical Disturbances of Pelvic Floor – fistula, rectal prolapse, descending perineum syndrome
Anorectal inflammation - Crohn’s disease, ulcerative colitis, radiation proctitis, anorectal infection
Central nervous system disease – Dementia, stroke, brain tumors, spinal cord lesions, multiple system atrophy (Shy Drager’s syndrome), 
multiple sclerosis
Bowel disturbances - diarrhea (eg, irritable bowel syndrome, post-cholecystectomy diarrhea) and constipation with or without fecal impaction/
overflow diarrhea.
More than one mechanism may be contributory in some patients.
Reproduced with permission Bharucha A. Fecal Incontinence. Gastroenterology. 2003;124(6):1672–85.
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Table 4
Suggestions for Future Research in Fecal Incontinence
Area Topics
Epidemiology • Evaluate the natural history of FI*
• Assess the impact of modifying risk factors on incidence and natural history of FI *
• Assess the patient’s perspective in the measurement of FI
• Further validate psychometric properties of instruments for evaluating symptom severity and QOL in FI
• Develop novel methods of administering questionnaires using IRT and CAT that may improve the 
measurement of FI with less burden for patients
Low rates of 
consulting and low 
rates of screening by 
providers
• Facilitate screening for FI by providers (e.g., effective tools, educate providers) and health-seeking 
behavior in those with FI (e.g., reduce the stigma associated with FI, and identify a well known 
personality to advocate for FI) *
• Assess if specific materials and methods are more successful in promoting health-seeking behavior in 
persons with FI in minority racial and ethnic groups.
Burden and Economic 
Impact
• Assess the associated costs of FI and incorporate cost effectiveness in diagnostic and treatment 
algorithms
Pathophysiology • Refine approaches for classifying FI.
• Assess whether the “phenotype” facilitates targeted therapy for FI.
• A better understanding of the interaction between stool consistency and anorectal functions, which 
contribute to FI.
• Identify the mechanisms of sphincter weakness in women without injury by imaging.
• Refine the ability of available imaging techniques to define the type (e.g., tear or scar) of anal sphincter 
injury and its functional consequences.
• Develop newer techniques to identify neurogenic anal sphincter injury.
• Clarify the mechanisms of increased rectal stiffness and develop pharmacological approaches to restore 
rectal reservoir function in FI.
• Elucidate the mechanisms by which obesity predisposes to FI.
• Understand the contributions of age, menopause, and chronic straining to anorectal dysfunctions and FI
*
These issues can also be evaluated specifically in the elderly
IRT – Item response theory
CAT – computerized adaptive testing
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